Histopathologic-genotypic correlations in retinitis pigmentosa and allied diseases

Ophthalmic Genetics

Volumn 26, Issue 2, 2005, Pages 91-100

  Ben Arie Weintrob, Yael ^a   Berson, Eliot L ^a   Dryja, Thaddeus P ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Congenital amaurosis; Mutation; Pathology; Photoreceptor; Retinal degeneration

Indexed keywords

ANOPHTHALMIA; COLOR BLINDNESS; CONGENITAL BLINDNESS; CORRELATION ANALYSIS; DOMINANT INHERITANCE; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HISTOPATHOLOGY; HUMAN; KEARNS SAYRE SYNDROME; LEBER CONGENITAL AMAUROSIS; MITOCHONDRIAL ENCEPHALOMYOPATHY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; RETINA CONE; RETINA DEGENERATION; RETINA DISEASE; RETINITIS PIGMENTOSA; REVIEW; S RETINA CONE SYNDROME; SPINOCEREBELLAR DEGENERATION; X CHROMOSOME LINKED DISORDER; ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CHILD; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PRESCHOOL CHILD; SYNDROME; X CHROMOSOME;

ATAXIA;

EYE PROTEIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLINDNESS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MUTATION; RETINAL DEGENERATION; RETINITIS PIGMENTOSA; SPINOCEREBELLAR ATAXIAS; SYNDROME;

EID: 24644494346     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.1080/13816810590968032     Document Type: Review

References (65)

1. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis. 2000;6:116-124.
2. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002;11:1219-1227.
3. Talmud PJ, Converse C, Krul E, et al. A novel truncated apoplipoprotein B (apo B55) in a patient with familial hypobetalipoproteinemia and atypical retinitis pigmentosa. Clin Genet. 1992;42:62-70.
4. Brosnahan DM, Kennedy SM, Converse CA, et al. Pathology of hereditary retinal degeneration associated with hypobetalipoproteinemia. Ophthalmology. 1994;101:38-45.
5. Kolb H, Gouras P. Electron microscopic observations of human retinitis pigmentosa, dominantly inherited. Invest Ophthalmol Vis Sci. 1974;13:487-498.
6. Berson EL, Rosner B, Sandberg MA, Dryja TP. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro23His). Arch Ophthalmol. 1991;109:92-101.
7. To K, Adamian M, Dryja TP, Berson EE. Retinal histopathology of an autopsy eye with advanced retinitis pigmentosa in a family with rhodopsin Glu181Lys. Am J Ophthalmol. 2000;130:790-792.
8. To K, Adamian M, Dryja TP, Berson EL. Histopathologic study of variation in severity of retinitis pigmentosa due to the dominant rhodopsin mutation Pro23His. Am J Ophthalmol. 2002;134:290-293.
9. To K, Adamian M, Berson EL. Histologic study of retinitis pig-mentosa due to a mutation in the RP13 gene (PRPC8): comparison with rhodopsin Pro23His, Cys110Arg, and Glu181Lys. Am J Ophthalmol. 2004;137:946-948.
10. Tucker GS, Jacobson SG. Morphological findings in retinitis pigmentosa with early diffuse rod dysfunction. Retina. 1988;8:30-41.
11. Jacobson SG, Kemp CM, Sung CH, Nathans J. Retinal function and rhodopsin levels in autosomal dominant retinitis pigmentosa with rhodopsin mutations. Am J Ophthalmol. 1991;112:256-271.
12. Sung CH, Davenport CM, Hennessey JC, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA. 1991;88:6481-6485.
13. Vaithinathan R, Berson EL, Dryja TP. Further screening of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. Genomics. 1994;21:461-463.
14. Dryja TP, McEvoy JA, McGee TL, Berson EL. Novel rhodopsin mutations G1y114Val and Gln184Pro in dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:3124-3127.
15. Li Z-Y, Jacobson SG, Milam AH. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry. Exp Eye Res. 1994;58:397-408.
16. Macke JP, Davenport CM, Jacobson SG, et al. Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. Am J Hum Genet. 1993;53:80-89.
17. Milam AH, Li Z-Y, Cideciyan AV, Jacobson SG. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1996;37:753-765.
18. Szamier RB, Berson EL. Retinal ultrastructure in advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1977;16:947-962.
19. Liu Q, Lyubarsky A, Skalet JH, et al. RP1 is required for the correct stacking of outer segment discs. Invest Ophthalmol Vis Sci. 2003;44:4171-4183.
20. Jacobson SG, Buraczynska M, Milam AH, et al. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene. Invest Ophthalmol Vis Sci. 1997;38:1983-1997.
21. Aguirre GD, Yashar BM, John SK, et al. Retinal histopathology of an XLRP carrier with a mutation in the RPGR exon ORF15. Exp Eye Res. 2002;75:431-443.
22. Szamier RB, Berson EL. Retinal histopathology of a carrier of X-chromosome linked retinitis pigmentosa. Ophthalmology. 1985;92:271-278.
23. Sharon D, Sandberg MA, Rabe VW, et al. RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet. 2003;73:1131-1146.
24. Chang TS, Johns DR, Walker D, et al. Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes. Arch Ophthalmol. 1993;111:1254-1262.
25. Martin JJ, van Regemorter N, Krols L, et al. On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol (Berl). 1994;88:277-286.
26. Mauger C, Del-Favero J, Ceuterick C, et al. Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody. Brain Res Mol Brain Res. 1999;74:35-43.
27. McLaughlin ME, Dryja TP. Ocular findings in spinocerebellar ataxia 7. Arch Ophthalmol. 2002;120:655-659.
28. To KW, Adamian M, Jakobiec FA, Berson EL. Olivopontocerebellar atrophy with retinal degeneration. An electroretinographic and histopathologic investigation. Ophthalmology. 1993;100:15-23.
29. Martin J, van Regemorter N, Del-Favero J, et al. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family. J Neurol Sci. 1999;168:37-46.
30. David G, Dürr A, Stevanin G, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet. 1998;7:165-170.
31. Neetens A, Martin JJ, Libert J, van den Ende P. Autosomal dominant cone dystrophy-cerebellar atrophy (ADCoCA) (modified ADCA Harding II). Neuro-ophthalmology. 1990;10:261-275.
32. Enevoldson TP, Sanders MD, Harding AE. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. Brain. 1994;117:445-460.
33. Heegaard S, Rosenberg T, Preising M, et al. An unusual retinal vascular morphology in connection with a novel AIPL1 mutation in Leber's congenital amaurosis. Br J Ophthalmol. 2003;87:980-983.
34. Porto FBO, Perrault I, Hicks D, et al. Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2). J Gene Med. 2002;4:390-396.
35. Milam AH, Rose L, Cideciyan AV, et al. The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration. Proc Natl Acad Sci USA. 2002;99:473-478.
36. Haider NB, Jacobson SG, Cideciyan AV, et al. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet. 2000;24:127-131.
37. Miano MG, Jacobson SG, Carothers A, et al. Pitfalls in homozygosity mapping. Am J Hum Genet. 2000;67:1348-1351.
38. To K, Adamian M, Jakobiec FA, Berson EL. Histopathologic and immunohistochemical study of dominant cone degeneration. Am J Ophthalmol. 1998;126:140-142.
39. Nishiguchi KM, Sokal I, Yang L, et al. A novel mutation (I143NT) in guanylate cyclase-activating protein 1 (GCAP1) associated with autosomal dominant cone degeneration. Invest Ophthalmol Vis Sci. 2004;45:3863-3870.
40. Reichel E, Bruce AM, Sandberg MA, Berson EL. An electroretinographic and molecular genetic study of X-linked cone degeneration. Am J Ophthalmol. 1989;108:540-547.
41. To KW, Adamian M, Jakobiec FA, Berson EL. Histopathologic and immunohistochemical study of an autopsy eye with X-linked cone degeneration. Arch Ophthalmol. 1998;116:100-103.
42. Kuntz CA, Jacobson SG, Cideciyan AV, et al. Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. Invest Ophthalmol Vis Sci. 1996;37:1772-1782.
43. Hayward C, Shu X, Cideciyan AV, et al. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum Mol Genet. 2003;12:2657-2667.
44. Fishman GA, Peachey NS. Rod-cone dystrophy associated with a rod system electroretinogram obtained under photopic conditions. Ophthalmology. 1989;96:913-918.
45. Marmor MF. Large rod-like photopic signals in a possible new form of congenital night blindness. Doc Ophthalmol. 1989;71:265-269.
46. Jacobson SG, Marmor MF, Kemp CM, Knighton RW. SWS (blue) cone hypersensitivity in a newly identified retinal degeneration. Invest Ophthalmol Vis Sci. 1990;31:827-838.
47. Hood DC, Cideciyan AV, Roman AJ, Jacobson SG. Enhanced S cone syndrome: evidence for an abnormally large number of S cones. Vision Res. 1995;35:1473-1481.
48. Greenstein VC, Zaidi Q, Hood DC, et al. The enhanced S cone syndrome: an analysis of receptoral and post-receptoral changes. Vision Res. 1996;36:3711-3722.
49. Hood DC, Cideciyan AV, Halevy DA, Jacobson SG. Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-waves. Vision Res. 1996;36:889-901.
50. Marmor MF, Tan F, Sutter EE, Bearse jr MA. Topography of cone electrophysiology in the enhanced S cone syndrome. Invest Ophthalmol Vis Sci. 1999;40:1866-1873.
51. Sharon D, Sandberg MA, Berson EL, Dryja TP. Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and clumped pigmentary retinal degeneration. Arch Ophthalmol. 2003;121:1316-1323.
52. Berson EL, Gouras P, Gunkel RD. Progressive cone degeneration, dominantly inherited. Arch Ophthalmol. 1968;80:77-83.
53. Humayun MS, De Juan jr E, Dagnelie G, et al. Visual perception elicited by electrical stimulation of retina in blind humans. Arch Ophthalmol. 2004;114:40-46.
54. Berger AS, Tezel TH, Del Priore LV Kaplan HJ. Photoreceptor transplantation in retinitis pigmentosa. Short-term follow-up. Ophthalmology. 2003;110:383-391.
55. Aramant RB, Seiler MJ, Ball SL. Successful cotransplantation of intact sheets of fetal retina with retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1999;40:1557-1564.
56. Zrenner E, Miliczek KD, Gabel VP, et al. The development of subretinal microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic Res. 1997;29:269-280.
57. Chow AY, Chow VY, Packo KH, et al. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. Arch Ophthalmol. 2004;122:460-469.
58. Sung C-H, Tai AW. Rhodopsin trafficking and its role in retinal dystrophies. Int Rev Cytol. 2000;195:215-267.
59. Chapple JP, Grayson C, Hardcastle AJ, et al. Unfolding retinal dystrophies: a role for molecular chaperones? Trends Mol Med. 2001;7:414-421.
60. Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002;277:34150-34160.
61. Cohen FE, Kelly JW. Therapeutic approaches to protein-misfolding diseases. Nature. 2003;426:905-909.
62. Berson EL. Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1993;34:1659-1676.
63. Nathans J, Thomas D, Hogness DS. Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. Science. 1986;232:193-202.
64. Nathans J, Piantanida TP, Eddy RL, et al. Molecular genetics of inherited variation in human color vision. Science. 1986;232:203-210.
65. Jensen RJ, Ziv OR, Rizzo JF. Thresholds for activation of rabbit retinal ganglion cells with relatively large, extracellular microelectrodes. Invest Ophthalmol Vis Sci. 2005;46:1486-1496.